Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value. 1993

S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
Divisione di Urologia, Ospedale Civile, Asti.

The cellular proliferative state of 18 incident cases of transitional cell carcinomas of the bladder treated with transurethral resection was blindly determined by two independent observers using Ki-67 monoclonal antibody and silver stain for nucleolar organizer regions (AgNORs). Ki-67 scores were significantly related to histological grade (WHO) (rs = 0.65, p < 0.01) and clinical stage (UICC) (rs = 0.46, p < 0.05). However, the follow-up analysis over a six year period did not demonstrate significant relationship between Ki-67 values and survival. AgNOR counting did not show significant association with any of the variables under study. The results of this investigation and the review of the pertinent literature suggest that the assessment of cell proliferation of bladder carcinoma by means of Ki-67 and AgNOR techniques is far from having immediate direct influence on patient management.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D009697 Nucleolus Organizer Region The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA. Nucleolar Organizer,Nucleolar Organizers,Nucleolus Organizer Regions,Organizer Region, Nucleolus,Organizer Regions, Nucleolus,Organizer, Nucleolar,Organizers, Nucleolar,Region, Nucleolus Organizer,Regions, Nucleolus Organizer
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females

Related Publications

S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
January 1997, Pathology, research and practice,
S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
January 2002, International urology and nephrology,
S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
February 1997, Pathology,
S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
October 1992, The British journal of ophthalmology,
S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
January 2005, Voprosy onkologii,
S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
November 1999, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
December 2003, Urological research,
S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
May 1991, Pathology, research and practice,
S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
January 1995, European urology,
S Zambelli, and A Zanin, and A Gaglio, and G Zai, and E Bosco, and A Andrion, and C Magnani
June 2012, Journal of clinical pathology,
Copied contents to your clipboard!